{"content":"<li class=\"n-box-item date-title\" data-end=\"1518843599\" data-start=\"1518757200\" data-txt=\"Monday, December 23, 2019\">Friday, February 16, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3332062\" data-ts=\"1518826632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IEP\" target=\"_blank\">IEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332062-nikkei-icahn-deason-cut-xerox-stake-after-fujifilm-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nikkei: Icahn, Deason cut Xerox stake after Fujifilm deal</a></h4><ul>   <li>Carl Icahn (NYSE:<a href='https://seekingalpha.com/symbol/IEP' title='Icahn Enterprises L.P.'>IEP</a>) and Darwin Deason -- who criticized Fujifilm's (<a href='https://seekingalpha.com/symbol/FUJIY' title='FUJIFILM Holdings Corp. ADR'>OTCPK:FUJIY</a>) deal to take majority control of Xerox (NYSE:<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a>) and <a href=\"https://seekingalpha.com/news/3330384-icahn-deason-urge-xerox-shareholders-oppose-deal\" target=\"_blank\">urged a vote against it</a> -- <a href=\"https://asia.nikkei.com/Business/Deals/Team-Icahn-cut-Xerox-stake-after-Fujifilm-deal-was-announced\" target=\"_blank\">sold part of their stakes</a> after the deal was announced, Nikkei reports.</li>    <li>The two hold about 32M shares of Xerox, down from 40M they held in January when urging Xerox to get out of the Fuji Xerox joint venture.</li>    <li>The two might have taken profits as Xerox shares <font color='green'>jumped 15%</font> on Jan. 31.</li>    <li>They've initiated a proxy fight and filed suit to block the deal.</li>    <li><a href='https://seekingalpha.com/symbol/FUJIY' title='FUJIFILM Holdings Corp. ADR'>OTCPK:FUJIY</a> <font color='green'>rose 2.2%</font> today; <a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a> <font color='green'>+0.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3332062\" data-linked=\"Nikkei: Icahn, Deason cut Xerox stake after Fujifilm deal\" data-tweet=\"$IEP $IEP $FUJIY - Nikkei: Icahn, Deason cut Xerox stake after Fujifilm deal https://seekingalpha.com/news/3332062-nikkei-icahn-deason-cut-xerox-stake-after-fujifilm-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3332062-nikkei-icahn-deason-cut-xerox-stake-after-fujifilm-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332060\" data-ts=\"1518824435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANET\" target=\"_blank\">ANET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332060-analysts-stick-up-for-arista-shares-slide-record-amount\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts stick up for Arista; shares slide by record amount</a></h4><ul>   <li>Arista Networks' (NYSE:<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a>) post-earnings sell-off extended to a record decline today despite a beat and <a href=\"https://seekingalpha.com/news/3331666-arista-networks-minus-11_4-percent-despite-43-percent-revenue-gain-q4\" target=\"_blank\">healthy revenue gains</a> -- perhaps suffering in comparison to a <a href=\"https://seekingalpha.com/news/3331584-cisco-hits-17-year-high-beat-analyst-target-hikes\" target=\"_blank\">blowout from bigger competitor Cisco Systems</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>).</li>    <li>Analysts stuck to their guns in the wake of the postmarket decline, particularly sticking up for an Arista outlook that many pointed to as the reason shares were selling off.</li>    <li>RBC's Mitch Steves says the forecast (for revenues of $450M-$468M, vs. consensus for $457.8M) still looks conservative and that upside from high data center expectations were likely priced in during the quarter. He still sees the company growing at 20-30% vs. a market growing in the high teens, and lowered his price target to $295, now implying 18% upside. (h/t Bloomberg)</li>    <li>Morgan Stanley's James Faucette thinks there's more demand in the market than Arista can currently satisfy, a situation that can help it it beat estimates this year and next if availability improves and hyperscale cloud demand recovers.</li>    <li>UBS raised its price target to $280; Needham has said it's buying the dip with a target of $315; and Barclays has boosted its target to $329, implying 32% upside. Gabelli took the step of downgrading to Hold.</li>    <li>Arista shares <font color='red'>fell 19%</font> today, but still only reached their lowest close since Jan. 5. They're still <font color='green'>up 5.9%</font> for 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3332060\" data-linked=\"Analysts stick up for Arista; shares slide by record amount\" data-tweet=\"$ANET $ANET $CSCO - Analysts stick up for Arista; shares slide by record amount https://seekingalpha.com/news/3332060-analysts-stick-up-for-arista-shares-slide-record-amount?source=tweet\" data-url=\"https://seekingalpha.com/news/3332060-analysts-stick-up-for-arista-shares-slide-record-amount\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332053\" data-ts=\"1518821343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBCC\" target=\"_blank\">LBCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332053-long-blockchain-gets-delisting-notice-from-nasdaq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long Blockchain gets delisting notice from Nasdaq</a></h4><ul>   <li>Former beverage maker Long Blockchain (<a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a>) says in an <a href=\"https://seekingalpha.com/filing/3892361\" target=\"_blank\">SEC filing</a> that it's gotten notice of delisting from Nasdaq.</li>    <li>The move comes under discretionary authority Nasdaq has under its Rule 5101. That rule reserves authority to manage listings to \"maintain the quality of and public confidence in its market, to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, and to protect investors and the public interest.\"</li>    <li>Nasdaq also said in its notification letter that it's revoking a prior notification that the company had regained compliance with the market value of listed securities requirement.</li>    <li>The company can request a hearing no later than 4 p.m. next Thursday; it says it intends to request such a hearing.</li>    <li>And even if the appeal is approved, the company still needs to get back in compliance with the MVLS rule by April 9.</li>    <li>Shares <font color='red'>fell 11%</font> today; they were <font color='red'>down 1.2%</font> at last postmarket report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3332053\" data-linked=\"Long Blockchain gets delisting notice from Nasdaq\" data-tweet=\"$LBCC - Long Blockchain gets delisting notice from Nasdaq https://seekingalpha.com/news/3332053-long-blockchain-gets-delisting-notice-from-nasdaq?source=tweet\" data-url=\"https://seekingalpha.com/news/3332053-long-blockchain-gets-delisting-notice-from-nasdaq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332051\" data-ts=\"1518820523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTX\" target=\"_blank\">PTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332051-after-hours-gainers-losers-2-16-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (2/16/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='green'>+12.6%</font>. <a href='https://seekingalpha.com/symbol/ALSN' title='Allison Transmission'>ALSN</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/SSTK' title='Shutterstock'>SSTK</a> <font color='green'>+1.7%</font>. <a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a> <font color='green'>+1.2%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color='red'>-3.3%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-2.3%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-1.8%</font>. <a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a> <font color='red'>-1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3332051\" data-linked=\"After Hours Gainers / Losers (2/16/2018)\" data-tweet=\"$PTX $PTX-OLD $ALSN - After Hours Gainers / Losers (2/16/2018) https://seekingalpha.com/news/3332051-after-hours-gainers-losers-2-16-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3332051-after-hours-gainers-losers-2-16-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332042\" data-ts=\"1518818040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332042-weekly-etf-gainers-losers-2-16-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers (2/16/18)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/TAN' title='Guggenheim Solar ETF'>TAN</a> <font color='green'>+10.9%</font>. <a href='https://seekingalpha.com/symbol/VNM' title='VanEck Vectors Vietnam ETF'>VNM</a> <font color='green'>+9.3%</font>. <a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='green'>+8.7%</font>. <a href='https://seekingalpha.com/symbol/EWY' title='iShares MSCI South Korea Capped ETF'>EWY</a> <font color='green'>+7.3%</font>. <a href='https://seekingalpha.com/symbol/KOL' title='VanEck Vectors Coal ETF'>KOL</a> <font color='green'>+7.2%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-15.0%</font>. <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='red'>-1.5%</font>. <a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a> <font color='red'>-1.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3332042\" data-linked=\"Weekly ETF Gainers / Losers (2/16/18)\" data-tweet=\"$TAN $VNM $REMX - Weekly ETF Gainers / Losers (2/16/18) https://seekingalpha.com/news/3332042-weekly-etf-gainers-losers-2-16-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3332042-weekly-etf-gainers-losers-2-16-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332035\" data-ts=\"1518816329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VJET\" target=\"_blank\">VJET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332035-voxeljetminus-15_5-after-downside-guidance-updates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Voxeljet -15.5% after downside guidance updates</a></h4><ul><li>        Voxeljet (NYSE:<a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a>) <a href=\"https://seekingalpha.com/pr/17077563-voxeljet-ag-issues-financial-guidance-year-ending-december-31-2018-announces-preliminary\" target=\"_blank\">updates</a> its FY18 guidance with revenue from &euro;28M to &euro;30M euros, up from the previous &euro;26M to &euro;28M (consensus: &euro;36.81M).</li><li>               More guidance: Gross margin, +40%; SG&amp;A expenses, &euro;11M to &euro;12M; R&amp;D expenses, &euro;5M to &euro;6M; Depreciation and amortization expense, &euro;3.75M to &euro;4M; adjusted EBITDA, neutral-to-positive; capital expenditures, &euro;5.5M to &euro;6.5M.&nbsp;</li><li>               Q1 guidance has revenue from &euro;4.5M to &euro;5.5M (consensus: &euro;6.83M).&nbsp;</li><li>               Voxeljet will release Q4 and FY17 results aftermarket on March 29. FY17 guidance has revenue from &euro;22.5M to &euro;23.5M (consensus: &euro;29.57M) due to a weaker 1H.&nbsp;</li><li>               Voxeljet shares are&nbsp;<font color='red'>down 15.5%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3332035\" data-linked=\"Voxeljet -15.5% after downside guidance updates\" data-tweet=\"$VJET - Voxeljet -15.5% after downside guidance updates https://seekingalpha.com/news/3332035-voxeljetminus-15_5-after-downside-guidance-updates?source=tweet\" data-url=\"https://seekingalpha.com/news/3332035-voxeljetminus-15_5-after-downside-guidance-updates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332020\" data-ts=\"1518813918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DM\" target=\"_blank\">DM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332020-dominion-energy-midstreamminus-4-national-grid-cashes-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dominion Energy Midstream -4% as National Grid cashes out</a></h4><ul>     <li>Dominion Energy Midstream Partners (<a href='https://seekingalpha.com/symbol/DM' title='Dominion Midstream Partners LP'>DM</a> <font color='red'>-4%</font>) sinks to a 52-week low as National Grid (<a href='https://seekingalpha.com/symbol/NGG' title='National Grid plc'>NGG</a> <font color='green'>+0.8%</font>) reportedly <a href=\"https://www.investorvillage.com/smbd.asp?mb=5028&amp;mn=84814&amp;pt=msg&amp;mid=18005826\" target=\"_blank\">divests its holdings</a> in the company.</li>     <li>Sources say Deutsche Bank will reoffer ~6.8M units in a range of $25.55-$26.10/unit, a 4.4%-6.6% discount to DM's Thursday closing price.</li>     <li>DM issued the units to NGG in August 2015 to acquire a 26% ownership stake in the Iroquois Gas Transmission System; the U.K. power network operator was DM's no. 2 shareholder, below only parent Dominion Energy (<a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a> <font color='green'>+0.4%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3332020\" data-linked=\"Dominion Energy Midstream -4% as National Grid cashes out\" data-tweet=\"$DM $DM $NGG - Dominion Energy Midstream -4% as National Grid cashes out https://seekingalpha.com/news/3332020-dominion-energy-midstreamminus-4-national-grid-cashes-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3332020-dominion-energy-midstreamminus-4-national-grid-cashes-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332015\" data-ts=\"1518812613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332015-riot-blockchain-chief-orourke-takes-issue-cnbc-report-shares-down-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Riot Blockchain chief O&#39;Rourke takes issue with CNBC report; shares down 38%</a></h4><ul><li>In a <a href=\"https://seekingalpha.com/pr/17077486-riot-blockchain-provides-shareholder-update\" target=\"_blank\">statement</a>, Riot Blockchain (<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-37.7%</font>)&nbsp;CEO John O'Rourke calls CNBC's critical report a \"negative one-sided piece\" that ignores his firm's many accomplishments. To wit:</li><li>The company entered the blockchain space via its investment in Canadian digital currency exchange Coinsquare, its 12.5% stake currently worth CAD$50M.</li><li>It now owns 8,000 ASIC cryptocurrency mining machines. When deployed in full, its hashing power will be over 110 Petahash of SHA 256 Bitcoin mining power and 252 Gigahash of Scrypt for Litecoin mining.</li><li>Letter of intent signed to acquire a CFTC-licensed registrant which will enable the company to launch a digital currency exchange and futures brokerage in the U.S.</li><li>Registered and acquired 500 bitcoins in the U.S. Marshals Service auction.</li><li>Acquired a majority interest in telecom-focused blockchain technology solutions provider Tess.</li><li>Beefed up management team.</li><li>Mr. O'Rourke explains that he adjourned the shareholders' meeting due to a lack of a quorum and expects to reconvene the meeting next quarter. As far as his stock sales are concerned, he says he sold less than 10% of his holdings at year-end 2017 to cover tax obligations.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331945-cnbc-investigates-questionable-riot-blockchain-shares-plummet-21_9-percent\" target=\"_blank\">CNBC investigates \"questionable\" Riot Blockchain; shares plummet 21.9%</a> (Feb. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3332015\" data-linked=\"Riot Blockchain chief O&#39;Rourke takes issue with CNBC report; shares down 38%\" data-tweet=\"$RIOT - Riot Blockchain chief O&#39;Rourke takes issue with CNBC report; shares down 38% https://seekingalpha.com/news/3332015-riot-blockchain-chief-orourke-takes-issue-cnbc-report-shares-down-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3332015-riot-blockchain-chief-orourke-takes-issue-cnbc-report-shares-down-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332014\" data-ts=\"1518812345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUY\" target=\"_blank\">AUY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332014-yamana-goldminus-10-after-posting-surprise-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yamana Gold -10% after posting surprise Q4 loss</a></h4><ul>     <li>Yamana Gold (<a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color='red'>-10.3%</font>) is sharply lower after reporting a large <a href=\"https://seekingalpha.com/news/3331759-yamana-gold-eps-0_20\" target=\"_blank\">Q4 loss</a> vs. analyst expectations of $0.03 EPS and a slight revenue drop.</li>     <li>AUY reports Q4 production totaled 259.6K oz. from its six producing  mines, as well as 1.17M oz. of silver and 34.7M lbs. of copper.</li>     <li>AUY forecasts production of 1.01M gold equiv. oz. with gold output of 900K oz. for 2018, 1.08M gold equiv. oz. for 2019, and 1.15M oz. for 2020, with gold production expected to rise mostly because of increases at Canadian Malartic, Jacobina and Minera Florida, and with new production from Cerro Moro.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3332014\" data-linked=\"Yamana Gold -10% after posting surprise Q4 loss\" data-tweet=\"$AUY - Yamana Gold -10% after posting surprise Q4 loss https://seekingalpha.com/news/3332014-yamana-goldminus-10-after-posting-surprise-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3332014-yamana-goldminus-10-after-posting-surprise-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332013\" data-ts=\"1518811988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332013-hasbro-higher-mattel-hints-smaller-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hasbro higher as Mattel hints at smaller focus</a></h4><ul> <li>Shares of Hasbro (NASDAQ:<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a>) are&nbsp;<font color='green'>up 2.33%</font>&nbsp;as Mattel management presents to analysts ahead of the New York Toy Fair.</li> <li>Mattel execs said the toy company plans to narrow its focus this year to focus more on improving margins, a development that could open up certain categories for Hasbro.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3332002-mattel-falls-execs-talk-strategy-new-york-toy-fair\" target=\"_blank\">Mattel falls as execs talk strategy at New York Toy Fair</a> (Feb. 16)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3332013\" data-linked=\"Hasbro higher as Mattel hints at smaller focus\" data-tweet=\"$HAS - Hasbro higher as Mattel hints at smaller focus https://seekingalpha.com/news/3332013-hasbro-higher-mattel-hints-smaller-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/3332013-hasbro-higher-mattel-hints-smaller-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332010\" data-ts=\"1518810907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCR\" target=\"_blank\">SNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332010-technology-top-gainers-losers-of-2_55-pm-2-16-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (2/16/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/MULE' title='MuleSoft'>MULE</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SSTI' title='ShotSpotter'>SSTI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/PAR' title='PAR Technology Corporation'>PAR</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/BL' title='BlackLine'>BL</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/COHU' title='Cohu, Inc.'>COHU</a> <font color='red'>-16%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3332010\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (2/16/18)\" data-tweet=\"$SNCR $SNCR $MULE - Technology - Top Gainers / Losers as of 2.55 pm (2/16/18) https://seekingalpha.com/news/3332010-technology-top-gainers-losers-of-2_55-pm-2-16-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3332010-technology-top-gainers-losers-of-2_55-pm-2-16-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332007\" data-ts=\"1518810738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HII\" target=\"_blank\">HII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332007-huntington-ingalls-hits-52-week-high-credit-suisse-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huntington Ingalls hits 52-week high as Credit Suisse upgrades</a></h4><ul>     <li>Huntington Ingalls (NYSE:<a href='https://seekingalpha.com/symbol/HII' title='Huntington Ingalls Industries, Inc.'>HII</a>) advances to a 52-week high as Credit Suisse <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11216905/credit-suisse-trump-budget-guidance-are-tailwinds-for-h\" target=\"_blank\">upgrades</a> shares to Outperform from Neutral with a $335 price target, hiked from $241, believing the company is well positioned for investors even with the stock up 30% YTD.</li>     <li>Citing top-line growth, continued solid margins and the latest pension contribution and recovery guidance, Credit Suisse expects substantial EPS growth in coming years and free cash flow starting in 2019.</li>     <li>Pension income appears largely sustainable in light of HII's 2018 and 2019 guidance and similar trends seen throughout the industry, the firm says.</li><li><a href=\"https://seekingalpha.com/news/3331357-huntington-ingalls-beats-0_17-beats-revenue\" target=\"_blank\">Earlier</a>: Huntington Ingalls beats by $0.17, beats on revenue (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3332007\" data-linked=\"Huntington Ingalls hits 52-week high as Credit Suisse upgrades\" data-tweet=\"$HII - Huntington Ingalls hits 52-week high as Credit Suisse upgrades https://seekingalpha.com/news/3332007-huntington-ingalls-hits-52-week-high-credit-suisse-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3332007-huntington-ingalls-hits-52-week-high-credit-suisse-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332006\" data-ts=\"1518809890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLD\" target=\"_blank\">CLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332006-cloud-peak-energyminus-23-q4-revenues-shipments-sink\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloud Peak Energy -23% as Q4 revenues, shipments sink</a></h4><ul>     <li>Cloud Peak Energy (<a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='red'>-22.8%</font>) plunges despite reporting better than expected <a href=\"https://seekingalpha.com/news/3331668-cloud-peak-energy-beats-0_26-misses-revenue\" target=\"_blank\">Q4 earnings</a>, as revenue fell 6% to $214M and realized price per ton sold fell to $11.98 from $12.15 a year earlier.</li>     <li>CLD says adjusted EBITDA of $19M and shipments of 13.5M tons during Q4 both were significantly below year-ago adjusted EBITDA of $40M and shipments of 16.7M tons.</li>     <li>For 2018, CLD plans to ship 52M-56M tons, with current commitments to sell 45M tons which includes 2.5M tons contracted with  export customers.</li><li>CLD expects 2018 capex of $15M-$25M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3332006\" data-linked=\"Cloud Peak Energy -23% as Q4 revenues, shipments sink\" data-tweet=\"$CLD $CLDPQ - Cloud Peak Energy -23% as Q4 revenues, shipments sink https://seekingalpha.com/news/3332006-cloud-peak-energyminus-23-q4-revenues-shipments-sink?source=tweet\" data-url=\"https://seekingalpha.com/news/3332006-cloud-peak-energyminus-23-q4-revenues-shipments-sink\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332002\" data-ts=\"1518808105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332002-mattel-falls-execs-talk-strategy-new-york-toy-fair\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel falls as execs talk strategy at New York Toy Fair</a></h4><ul>     <li>Mattel (<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-4.3%</font>) swings lower as executives provide an update at a meeting in front of the New York Toy Fair.</li><li>Management sets medium-term objectives of&nbsp; mid-to-high single digit revenue growth and an operating margin of 15% or higher.</li><li><a href=\"http://investor.shareholder.com/mattel/events.cfm\" target=\"_blank\">Mattel presentation slides</a></li><li><a href=\"http://investor.shareholder.com/mattel/events.cfm\" target=\"_blank\">Mattel presentation webcast</a></li>      </ul><div class=\"tiny-share-widget\" data-id=\"3332002\" data-linked=\"Mattel falls as execs talk strategy at New York Toy Fair\" data-tweet=\"$MAT - Mattel falls as execs talk strategy at New York Toy Fair https://seekingalpha.com/news/3332002-mattel-falls-execs-talk-strategy-new-york-toy-fair?source=tweet\" data-url=\"https://seekingalpha.com/news/3332002-mattel-falls-execs-talk-strategy-new-york-toy-fair\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3332001\" data-ts=\"1518807716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKS\" target=\"_blank\">AKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3332001-energy-materials-top-gainers-losers-of-2-00-pm-2-16-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/16/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/YTEN' title='Yield10 Bioscience, Inc.'>YTEN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/UAN' title='CVR Partners, LP'>UAN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/EPE' title='EP Energy Corporation'>EPE</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3332001\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/16/2018)\" data-tweet=\"$AKS $AKS $X - Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/16/2018) https://seekingalpha.com/news/3332001-energy-materials-top-gainers-losers-of-2-00-pm-2-16-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3332001-energy-materials-top-gainers-losers-of-2-00-pm-2-16-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331987\" data-ts=\"1518804023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVG\" target=\"_blank\">NAVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331987-financials-top-5-gainers-losers-of-1-00-pm-02-16-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (02/16/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NAVG' title='The Navigators Group, Inc.'>NAVG</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/NSEC' title='National Security Group, Inc.'>NSEC</a> <font color='green'>+12%</font>.<a href='https://seekingalpha.com/symbol/COWN' title='Cowen Group, Inc.'>COWN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NMIH' title='NMI Holdings, Inc.'>NMIH</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NHLD' title='National Holdings Corp.'>NHLD</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RM' title='Regional Management Corp.'>RM</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331987\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (02/16/2018)\" data-tweet=\"$NAVG $NAVG $NSEC - Financials - Top 5 Gainers / Losers as of 1:00 PM (02/16/2018) https://seekingalpha.com/news/3331987-financials-top-5-gainers-losers-of-1-00-pm-02-16-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331987-financials-top-5-gainers-losers-of-1-00-pm-02-16-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331979\" data-ts=\"1518803052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XTNT\" target=\"_blank\">XTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331979-midday-gainers-losers-2-16-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (2/16/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='green'>+54%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/GEN' title='Genesis Healthcare, Inc.'>GEN</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Inc.'>ATOM</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/MULE' title='MuleSoft'>MULE</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/NAVG' title='The Navigators Group, Inc.'>NAVG</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> APRI <font color='red'>-66%</font>. <a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/PXLW' title='Pixelworks, Inc.'>PXLW</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/COHU' title='Cohu, Inc.'>COHU</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ASFI' title='Asta Funding, Inc.'>ASFI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-16%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331979\" data-linked=\"Midday Gainers / Losers (2/16/2018)\" data-tweet=\"$XTNT $XTNT $FTFT - Midday Gainers / Losers (2/16/2018) https://seekingalpha.com/news/3331979-midday-gainers-losers-2-16-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331979-midday-gainers-losers-2-16-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331977\" data-ts=\"1518802838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331977-abbvies-jak1-inhibitor-upadacitinib-shows-durable-treatment-effect-in-mid-stage-crohns-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie&#39;s JAK1 inhibitor upadacitinib shows durable treatment effect in mid-stage Crohn&#39;s study; shares up 3%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17077373-abbvie-announces-new-phase-2-data-upadacitinib-showing-clinical-endoscopic-outcomes-crohns\" target=\"_blank\">Updated results</a> from the extension portion of a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02365649?term=nct02365649&amp;rank=1\" target=\"_blank\">CELEST</a>, evaluating AbbVie's (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='green'>+3%</font>)&nbsp;JAK1 inhibitor upadacitinib in adult Crohn's disease patients who had not responded adequately to prior immunomodulator or tumor necrosis factor alpha antagonist therapy showed a sustained treatment benefit. The data are being presented at ECCO in Vienna, Austria.</li><li>CELEST is a 52-week randomized, double-blind trial consisting of a 16-week dose-ranging induction and a 36-week extension phase. All participants who completed the 16-week portion were re-randomized 1:1:1 to receive one of the following upadacitinib dosing regimens: 3 mg twice daily, 12 mg twice daily or 24 mg once daily for 36 weeks. The 24 mg arm was later stopped and replaced with a 6 mg twice-daily arm.</li><li>The co-primary endpoints were the proportion of patients achieving clinical remission and endoscopic remission up to week 16.</li><li>In patients who responded clinically by week 16, 41% of those receiving the 12 mg twice-daily dose achieved clinical remission at week 52. For the 3 mg, 6 mg and 24 mg arms, the rates of clinical remission were 25%, 29% and 32%, respectively.</li><li>The proportions who achieved endoscopic remission at week 52 in the 3 mg, 6 mg, 12 mg and 24 mg arms were 16%, 21%, 24% and 26%, respectively.</li><li>Upadacitinib (formerly ABT-494) is in Phase 3 development for ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, Crohn's disease and atopic dermatitis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331977\" data-linked=\"AbbVie&#39;s JAK1 inhibitor upadacitinib shows durable treatment effect in mid-stage Crohn&#39;s study; shares up 3%\" data-tweet=\"$ABBV - AbbVie&#39;s JAK1 inhibitor upadacitinib shows durable treatment effect in mid-stage Crohn&#39;s study; shares up 3% https://seekingalpha.com/news/3331977-abbvies-jak1-inhibitor-upadacitinib-shows-durable-treatment-effect-in-mid-stage-crohns-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3331977-abbvies-jak1-inhibitor-upadacitinib-shows-durable-treatment-effect-in-mid-stage-crohns-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331976\" data-ts=\"1518802456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331976-gbh-sets-apple-target-18_5-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GBH sets Apple target at 18.5% upside</a></h4><ul><li>GBH Insights <a href=\"https://www.cnbc.com/2018/02/16/apple-aapl-stock-gbhs-dan-ives-says-the-panic-is-over.html\" target=\"_blank\">sets</a> its Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) price target at $205 (18.5% upside to yesterday&rsquo;s close) citing the upcoming buybacks, a growing services business, and strength in China.</li><li>Analyst Dan Ives says the &ldquo;March guidance hangover appears to have dissipated&rdquo; and estimates that Apple has about 350M iPhones in the &ldquo;window of opportunity&rdquo; to upgrade in the next 12 to 18 months.</li><li>Ives expects three new iPhones this year that could capture customers scared off by the premium iPhone X.</li><li>The analyst predicts the services division (Music, Care, and App Store) will hit $50B in annual revenue by 2020.</li><li>Apple shares are&nbsp;<font color='green'>up 0.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331976\" data-linked=\"GBH sets Apple target at 18.5% upside\" data-tweet=\"$AAPL - GBH sets Apple target at 18.5% upside https://seekingalpha.com/news/3331976-gbh-sets-apple-target-18_5-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3331976-gbh-sets-apple-target-18_5-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331975\" data-ts=\"1518801137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331975-commerce-department-recommends-major-tariffs-on-steel-and-aluminum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commerce Department recommends major tariffs on steel and aluminum</a></h4><ul>     <li>Steel and aluminum shares are rallying as the U.S. Department of Commerce <a href=\"https://www.commerce.gov/news/press-releases/2018/02/secretary-ross-releases-steel-and-aluminum-232-reports-coordination\" target=\"_blank\">recommends tariffs</a>: <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+12.7%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+12.2%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+3.3%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+4.8%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+4%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+5.9%</font>, <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+5.4%</font>, <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='green'>+2.4%</font>, <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='green'>+2.2%</font>, <a href='https://seekingalpha.com/symbol/TS' title='Tenaris S.A.'>TS</a> <font color='green'>+3.7%</font>, <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='green'>+6.8%</font>, <a href='https://seekingalpha.com/symbol/ZEUS' title='Olympic Steel, Inc.'>ZEUS</a> <font color='green'>+3.5%</font>, <a href='https://seekingalpha.com/symbol/SCHN' title='Schnitzer Steel Industries, Inc.'>SCHN</a> <font color='green'>+2.4%</font>, <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='green'>+4.7%</font>, <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+8%</font>, <a href='https://seekingalpha.com/symbol/KALU' title='Kaiser Aluminum Corporation'>KALU</a> <font color='green'>+2.2%</font>, <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a> <font color='green'>+2.1%</font>.</li>     <li>The DoC recommends a 7.7% tariff  on all aluminum exports, with higher duties of 23.6% on products from China, Russian, Venezuela and Vietnam.</li>     <li>The Department also recommends global steel duties of 24% on all imports, with a ~53% tariff on steel  imports from Brazil, China, India, Russia and several other countries.</li>     <li>Pres. Trump has until April 20 to make a final decision.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a>, <a href='https://seekingalpha.com/symbol/JJU-OLD' title='iPath Dow Jones-UBS Aluminum Total Return Sub-IndexS ETN'>JJU-OLD</a>, <a href='https://seekingalpha.com/symbol/FOIL' title='iPath Pure Beta Aluminum ETN'>FOIL</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331975\" data-linked=\"Commerce Department recommends major tariffs on steel and aluminum\" data-tweet=\"$X $X $AKS - Commerce Department recommends major tariffs on steel and aluminum https://seekingalpha.com/news/3331975-commerce-department-recommends-major-tariffs-on-steel-and-aluminum?source=tweet\" data-url=\"https://seekingalpha.com/news/3331975-commerce-department-recommends-major-tariffs-on-steel-and-aluminum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>141&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331974\" data-ts=\"1518800500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTFT\" target=\"_blank\">FTFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331974-consumer-top-gainers-losers-of-12-00-pm-2-16-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (2/16/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ABAC-OLD' title='Renmin Tianli Group'>ABAC-OLD</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/HOME' title='At Home Group'>HOME</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331974\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (2/16/2018)\" data-tweet=\"$FTFT $FTFT $PME - Consumer - Top Gainers / Losers as of 12:00 pm (2/16/2018) https://seekingalpha.com/news/3331974-consumer-top-gainers-losers-of-12-00-pm-2-16-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331974-consumer-top-gainers-losers-of-12-00-pm-2-16-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331972\" data-ts=\"1518800233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331972-teva-launches-asthma-treatment-qvar-redihaler-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva launches asthma treatment QVAR RediHaler in U.S.</a></h4><ul><li>Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+1%</font>) <a href=\"https://seekingalpha.com/pr/17077382-teva-announces-u-s-launch-qvar-redihaler-beclomethasone-dipropionate-hfa-inhalation-aerosol\" target=\"_blank\">announces </a>the commercial availability of QVAR RediHaler (beclomethasone dipropionate HFA) in the U.S. for the maintenance treatment of asthma in patients at least four years old.</li><li>The company says it will discontinue selling QVAR but RediHaler will be priced similarly.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331972\" data-linked=\"Teva launches asthma treatment QVAR RediHaler in U.S.\" data-tweet=\"$TEVA - Teva launches asthma treatment QVAR RediHaler in U.S. https://seekingalpha.com/news/3331972-teva-launches-asthma-treatment-qvar-redihaler-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3331972-teva-launches-asthma-treatment-qvar-redihaler-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331966\" data-ts=\"1518799608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331966-novartis-to-sell-u-s-generics-unit-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novartis to sell U.S. generics unit - Reuters</a></h4><ul><li>Reuters <a href=\"https://uk.reuters.com/article/us-novartis-genericdrugs/novartis-readies-to-auction-u-s-generic-pills-business-sources-idUKKCN1G01SW\" target=\"_blank\">reports </a>that Novartis (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='green'>+0.8%</font>), apparently out of patience with the struggling unit, is <a href=\"https://uk.reuters.com/article/us-novartis-genericdrugs/novartis-readies-to-auction-u-s-generic-pills-business-sources-idUKKCN1G01SW\" target=\"_blank\">preparing to sell</a> its U.S. generics business amidst fierce competition and downward pricing pressure.</li><li>Observers believe the unit could fetch $1.6B, representing an 8x multiple of EBITDA of $200M.</li><li>Novartis is also reportedly mulling a spin-off of eyecare unit Alcon.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331966\" data-linked=\"Novartis to sell U.S. generics unit - Reuters\" data-tweet=\"$NVS - Novartis to sell U.S. generics unit - Reuters https://seekingalpha.com/news/3331966-novartis-to-sell-u-s-generics-unit-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3331966-novartis-to-sell-u-s-generics-unit-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331963\" data-ts=\"1518798793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331963-cnbc-investigation-riot-blockchain-reveals-investor-long-history-tiny-companies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC investigation into Riot Blockchain reveals investor with long history with tiny companies</a></h4><ul><li>CNBC <a href=\"https://www.cnbc.com/2018/02/16/public-company-changes-name-to-riot-blockchain-sees-shares-rocket.html\" target=\"_blank\">reported</a> that its inquiry into Riot Blockchain's (<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-31.9%</font>) dubious history revealed the name of one Barry Honig. It seems he became active in the company when it was a veterinary testing firm called Bioptix in April 2016.</li><li>A&nbsp;<a href=\"https://www.sec.gov/Archives/edgar/data/1167419/000107997317000521/0001079973-17-000521-index.htm\" target=\"_blank\">prospectus </a>filed with the SEC on August 24, 2017, showed Mr. Honig owning 543K shares and <a href=\"https://www.bloomberg.com/profiles/companies/1246924D:US-grq-consultants-inc\" target=\"_blank\">GRQ Consultants</a>, which he founded and heads, owning 30.6K shares. His father, Alan Honig, was also on board, owning 20K shares.</li><li>Another investor was Mark Groussman, owner of 160K shares, who leads another consultancy called Melechdavid, owner of 340K shares.</li><li>Mr. Honig and Mr. Groussman have a <a href=\"http://www.teribuhl.com/2017/04/05/honig-and-friends-sue-john-mcafee-because-they-didnt-make-enough-money-in-mgt-capital-deal/\" target=\"_blank\">long history</a> together. For example, they were both involved with <a href=\"https://seekingalpha.com/article/1874651-musclepharm-fails-to-pump-me-up\" target=\"_blank\">MusclePharm </a>in 2012, providing services paid in stock, each accumulating a 4.2% stake. Both men also worked on a reverse merger involving American Strategic Minerals.</li><li>A <a href=\"https://www.sec.gov/Archives/edgar/data/1167419/000165495417009301/honig-riot13g.htm\" target=\"_blank\">13G </a>filed filed on October 11, 2017 for Riot Blockchain/F/K/A Bioptix reported a 639,920-share stake by Mr. Honig's brother Jonathan. A <a href=\"https://www.sec.gov/Archives/edgar/data/1167419/000149315217011558/sc13g.htm\" target=\"_blank\">13G </a>filed two days later listed Mr. Groussman's 399,020-share stake.</li><li>Diligent investors will, no doubt, be looking into RIOT through a sharper lens.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331945-cnbc-investigates-questionable-riot-blockchain-shares-plummet-21_9-percent\" target=\"_blank\">CNBC investigates \"questionable\" Riot Blockchain; shares plummet 21.9%</a> (Feb. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331963\" data-linked=\"CNBC investigation into Riot Blockchain reveals investor with long history with tiny companies\" data-tweet=\"$RIOT - CNBC investigation into Riot Blockchain reveals investor with long history with tiny companies https://seekingalpha.com/news/3331963-cnbc-investigation-riot-blockchain-reveals-investor-long-history-tiny-companies?source=tweet\" data-url=\"https://seekingalpha.com/news/3331963-cnbc-investigation-riot-blockchain-reveals-investor-long-history-tiny-companies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331964\" data-ts=\"1518798778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVE\" target=\"_blank\">INVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331964-identiv-reports-preliminary-q4-fy17-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Identiv reports preliminary Q4 &amp; FY17 Results</a></h4><ul>     <li>Identive (<a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='green'>+2.6%</font>) expects to report Q4 revenue in the range of $16.5M - $16.7M vs. a consensus of $16.55M. Net loss for the quarter is expected to be in the range between $4.3M - $4.7M. Non-GAAP adjusted EBITDA is expected in the range of $1.3M - $1.5M.</li>     <li>The resulting preliminary revenue for FY17 ranges between $60.2M - $60.4M vs. a consensus of $60.2. Net loss for the year is expected to be in the range of $7.9M - $8.3M &amp; Non-GAAP adjusted EBITDA is expected in the range of $2.7M - $2.9M.</li>     <li>In addition, the company&nbsp; has closed its <a href=\"https://seekingalpha.com/news/3328481-identiv-acquires-video-tech-data-analytics-company-shares-plus-4_5-percent\" target=\"_blank\">previously announced acquisition</a> of 3VR, which will strengthen the Company&rsquo;s position in the premises security market.</li><li><a href=\"https://seekingalpha.com/pr/17076716-identiv-closes-acquisition-3vr-reports-preliminary-fourth-quarter-fiscal-year-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331964\" data-linked=\"Identiv reports preliminary Q4 &amp; FY17 Results\" data-tweet=\"$INVE - Identiv reports preliminary Q4 &amp; FY17 Results https://seekingalpha.com/news/3331964-identiv-reports-preliminary-q4-fy17-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3331964-identiv-reports-preliminary-q4-fy17-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331957\" data-ts=\"1518797708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HHS\" target=\"_blank\">HHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331957-harte-hanksplus-2_8-holder-fondren-boosts-stake-calls-for-changes-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harte Hanks +2.8% as holder Fondren boosts stake, calls for changes again</a></h4><ul>   <li>Harte Hanks (NYSE:<a href='https://seekingalpha.com/symbol/HHS' title='Harte Hanks Inc.'>HHS</a>) shareholder Fondren Management has again boosted its stake and is keeping up a call for a new chairman and a reconstituted board.</li>    <li>Shares are <font color='green'>up 2.8%</font>.</li>    <li>In an <a href=\"https://seekingalpha.com/filing/3890058\" target=\"_blank\">SEC&nbsp;filing</a>, the firm and Bradley Radoff are now disclosing a stake of about 7.2%, up from <a href=\"https://seekingalpha.com/news/3322702-harte-hanks-shareholder-raises-holdings-presses-board-change\" target=\"_blank\">about 5.9% reported Jan. 12</a>.</li>    <li>Meanwhile, Fondren says it's had \"numerous conversations with members of the Board and senior management of the Issuer and continue to demand that the chairman resign and that the Board be meaningfully reconstituted and that the Issuer adhere to best practices of corporate governance.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331957\" data-linked=\"Harte Hanks +2.8% as holder Fondren boosts stake, calls for changes again\" data-tweet=\"$HHS - Harte Hanks +2.8% as holder Fondren boosts stake, calls for changes again https://seekingalpha.com/news/3331957-harte-hanksplus-2_8-holder-fondren-boosts-stake-calls-for-changes-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3331957-harte-hanksplus-2_8-holder-fondren-boosts-stake-calls-for-changes-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331931\" data-ts=\"1518796849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEN\" target=\"_blank\">GEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331931-healthcare-top-5-gainers-losers-of-11-00-2-16-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/16/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GEN' title='Genesis Healthcare, Inc.'>GEN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> APRI <font color='red'>-64%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331931\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/16/2018)\" data-tweet=\"$GEN $GEN $CATB - Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/16/2018) https://seekingalpha.com/news/3331931-healthcare-top-5-gainers-losers-of-11-00-2-16-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331931-healthcare-top-5-gainers-losers-of-11-00-2-16-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331949\" data-ts=\"1518796516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VFC\" target=\"_blank\">VFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331949-post-earnings-decline-for-vf-corp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings decline for VF Corp</a></h4><ul> <li>VF Corp (NYSE:<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a>) is&nbsp;<font color='red'>down 8.23%</font>&nbsp;on just the slightest of a miss on both Q4 revenue and EPS.</li> <li>Looking ahead, the retailer expects Q1 revenue of $2.90B vs. $2.95B and EPS of $0.65 vs. $0.63 consensus.</li> <li>\"We remain in the early phase of a multi-year journey to become a purpose led, agile, consumer centric organization. I am pleased with our early progress and look forward to building on our momentum in 2018,\" promises CEO Steve Rendle.</li> <li>Shares of VFC are up 46% over the last 52 weeks.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331816-v-f-misses-0_01-misses-revenue\" target=\"_blank\">V.F. misses by $0.01, misses on revenue</a> (Feb. 16)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331949\" data-linked=\"Post-earnings decline for VF Corp\" data-tweet=\"$VFC - Post-earnings decline for VF Corp https://seekingalpha.com/news/3331949-post-earnings-decline-for-vf-corp?source=tweet\" data-url=\"https://seekingalpha.com/news/3331949-post-earnings-decline-for-vf-corp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331948\" data-ts=\"1518796369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNI\" target=\"_blank\">MNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331948-mcclatchyplus-1_8-revenue-beats-in-tough-ad-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McClatchy +1.8% as revenue beats in tough ad quarter</a></h4><ul>   <li>McClatchy (NYSEMKT:<a href='https://seekingalpha.com/symbol/MNI' title='The McClatchy Company'>MNI</a>) is <font color='green'>up 1.8%</font> after posting <a href=\"https://seekingalpha.com/news/3331909-mcclatchy-beats-revenue\" target=\"_blank\">Q4 earnings</a> where revenues declined though the company saw bright spots in subscribers and visitors.</li>    <li>Net income rose to $60.4M from $3.1M on a headline basis, but affected by numerous items including unique tax items and severance. Adjusted net income was $3.2M, down from a previous $12.9M.</li>    <li>Revenues fell 6.7% with advertising headwinds including continued print declines and a soft holiday retail ad season.</li>    <li>Total ad revenues fell 12.7%. Digital-only ad revenues were up 9.6%, and total digital ad revenues rose 1%.</li>    <li>Direct marketing ad revenues fell 9.9%, negatively impacted by Hurricane Irma.</li>    <li>For 2018, it's expecting a \"milestone year\" where digital ad revenues exceed those in print (which \"remain volatile and are expected to decline\"). Digital subs will largely offset continued declines in print circulation, leading to \"low single digit revenue declines.\"</li>    <li><a href=\"http://www.mcclatchy.com/\" target=\"_blank\">Conference call</a> to come at noon ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17077236-mcclatchy-reports-fourth-quarter-2017-earnings\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331948\" data-linked=\"McClatchy +1.8% as revenue beats in tough ad quarter\" data-tweet=\"$MNI - McClatchy +1.8% as revenue beats in tough ad quarter https://seekingalpha.com/news/3331948-mcclatchyplus-1_8-revenue-beats-in-tough-ad-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3331948-mcclatchyplus-1_8-revenue-beats-in-tough-ad-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331945\" data-ts=\"1518796060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331945-cnbc-investigates-questionable-riot-blockchain-shares-plummet-21_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC investigates &quot;questionable&quot; Riot Blockchain; shares plummet 21.9%</a></h4><ul><li>           Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>)&nbsp;<font color='red'>plunges 21.9%&nbsp;</font>after a CNBC investigation into the vet product company adding blockchain to its name and profiting. </li><li> Riot started out as Bioptix, which had a vet product patent, before making a cryptocurrency exchange investment and then purchasing a crypto mining equipment company. Riot paid $11M for $2M in equipment, according to filings. </li><li> CNBC says this isn&rsquo;t Riot&rsquo;s only &ldquo;questionable&rdquo; behavior: &ldquo;A number of red flags in the company's SEC filings also might make investors leery: annual meetings that are postponed at the last minute, insider selling soon after the name change, dilutive issuances on favorable terms to large investors, SEC filings that are often Byzantine and, just this week, evidence that a major shareholder was getting out while everyone else was getting in.&rdquo; </li><li> Read the full investigation <a href=\"https://www.cnbc.com/2018/02/16/public-company-changes-name-to-riot-blockchain-sees-shares-rocket.html\" target=\"_blank\">here</a>.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3331945\" data-linked=\"CNBC investigates &quot;questionable&quot; Riot Blockchain; shares plummet 21.9%\" data-tweet=\"$RIOT - CNBC investigates &quot;questionable&quot; Riot Blockchain; shares plummet 21.9% https://seekingalpha.com/news/3331945-cnbc-investigates-questionable-riot-blockchain-shares-plummet-21_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3331945-cnbc-investigates-questionable-riot-blockchain-shares-plummet-21_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331943\" data-ts=\"1518795555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XTNT\" target=\"_blank\">XTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331943-xtant-medical-regains-compliance-nyse-american-after-converting-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xtant Medical regains compliance with NYSE American after converting debt</a></h4><ul><li>Thinly traded micro cap Xtant Medical Holdings (<a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='green'>+13.7%</font>) is up a 4x surge in volume, albeit on turnover of only 71K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17076874-xtant-medical-announces-compliance-nyse-american\" target=\"_blank\">announcement</a> that it has regained full compliance with listing requirements on NYSE American.</li><li>The company was deficient in total stockholders' equity which it addressed by converting certain 6.00% convertible senior unsecured notes into 2,275,745 shares of common stock on January 17, exchanging all other Notes into 10,401,309 common shares on February 14, privately placing 945,819 common shares and through its operations.</li><li>As of February 15, stockholders' equity was $47.4M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331943\" data-linked=\"Xtant Medical regains compliance with NYSE American after converting debt\" data-tweet=\"$XTNT - Xtant Medical regains compliance with NYSE American after converting debt https://seekingalpha.com/news/3331943-xtant-medical-regains-compliance-nyse-american-after-converting-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3331943-xtant-medical-regains-compliance-nyse-american-after-converting-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331942\" data-ts=\"1518795055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRR\" target=\"_blank\">RRR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331942-red-rock-stoked-deutsche-bank-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Rock stoked by Deutsche Bank confidence</a></h4><ul> <li>Red Rock Resorts (NYSE:<a href='https://seekingalpha.com/symbol/RRR' title='Red Rock Resorts'>RRR</a>) soars after Deutsche Bank issues a positive note on the casino stock.</li> <li>The firm calls the concerns over January gaming trends \"overblown\" considering the larger picture for the U.S. casino industry.</li> <li>Red Rock is&nbsp;<font color='green'>up 4.74%</font>&nbsp;to $34.00. Shares have traded in a range of $20.87 to $35.77 over the last 52 weeks.</li><li>Sources: CNBC, Bloomberg</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3331942\" data-linked=\"Red Rock stoked by Deutsche Bank confidence\" data-tweet=\"$RRR - Red Rock stoked by Deutsche Bank confidence https://seekingalpha.com/news/3331942-red-rock-stoked-deutsche-bank-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3331942-red-rock-stoked-deutsche-bank-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331941\" data-ts=\"1518794986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KAI\" target=\"_blank\">KAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331941-on-kadants-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Kadant&#39;s Q4</a></h4><ul><li>Kadant (<a href='https://seekingalpha.com/symbol/KAI' title='Kadant Inc.'>KAI</a> <font color='red'>-2.2%</font>) <a href=\"https://seekingalpha.com/pr/17076930-kadant-reports-fourth-quarter-fiscal-year-2017-results\" target=\"_blank\">reports</a> revenue rose 17% in Q4 after excluding the impact of acquisitions and foreign currency translation.</li><li>Papermaking Systems revenue expanded 30.4% to $112.19M.</li><li>Wood Processing Systems revenue grew 197.9% to $34M.</li><li>Revenue by Geography: North America: $68.39M (+44.2%); Europe: $44.82M (+51.3%); Asia: $24.79M (43.7%).</li><li>Gross margin rate squeezed 270 bps to 43.3% for the quarter.</li><li>Adjusted operating margin rate improved 320 bps to 13.8%.</li><li>Adjusted EBITDA expanded 88% to $26.5M; margin +380 bps to 17.8%.</li><li>Bookings for the quarter increased 29% Y/Y to $147M.</li><li><strong>Q1 Guidance</strong>: Revenue: $143M to $146M; Diluted EPS: $0.77 to $0.81; Adjusted EPS: $0.94 to $0.98.</li><li><strong>FY2018 Guidance</strong>: Revenue: $605M to $615M; Diluted EPS: $4.74 to $4.84; Adjusted EPS: $4.95 to $5.05.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331734-kadant-beats-0_06-beats-revenue\" target=\"_blank\">Kadant beats by $0.06, beats on revenue</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331941\" data-linked=\"More on Kadant&#39;s Q4\" data-tweet=\"$KAI - More on Kadant&#39;s Q4 https://seekingalpha.com/news/3331941-on-kadants-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3331941-on-kadants-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331939\" data-ts=\"1518794904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331939-activist-investor-reaffirms-135-share-price-for-nxp-semiconductors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist investor reaffirms $135/share price for NXP Semiconductors</a></h4><ul><li>        Elliott Advisors reaffirms its fair value view that NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>) is worth $135 per share on a standalone basis.</li><li>               The activist investor <a href=\"http://www.fairvaluefornxp.com/\" target=\"_blank\">released a presentation</a> defending its case.&nbsp;</li><li>               Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) offered $110 per share for NXP in October 2016 and the acquisition remains stuck in the regulatory process. Closing the deal would help Qualcomm defend a Broadcom takeover.&nbsp;</li><li>               NXP shares are&nbsp;<font color='green'>up 0.8%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3331939\" data-linked=\"Activist investor reaffirms $135/share price for NXP Semiconductors\" data-tweet=\"$NXPI $NXPI $QCOM - Activist investor reaffirms $135/share price for NXP Semiconductors https://seekingalpha.com/news/3331939-activist-investor-reaffirms-135-share-price-for-nxp-semiconductors?source=tweet\" data-url=\"https://seekingalpha.com/news/3331939-activist-investor-reaffirms-135-share-price-for-nxp-semiconductors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331938\" data-ts=\"1518794440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331938-johnson-johnsons-tremfya-shows-sustained-treatment-effect-in-late-stage-psoriasis-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Johnson &amp; Johnson&#39;s Tremfya shows sustained treatment effect in late-stage psoriasis study</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17077297-new-tremfya-guselkumab-data-demonstrates-long-term-skin-clearance-patients-moderate-severe\" target=\"_blank\">New data</a> from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02207244?cond=Plaque+Psoriasis&amp;intr=guselkumab&amp;titles=voyage+2&amp;spons=janssen&amp;phase=2&amp;rank=1\" target=\"_blank\">VOYAGE 2</a>, evaluating Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='green'>+0.9%</font>) unit Janssen Pharmaceuticals' <a href=\"https://www.tremfya.com/\" target=\"_blank\">TREMFYA </a>(guselkumab) in patients with moderate-to-severe plaque psoriasis showed a durable treatment effect. The results will be presented tomorrow at the American Academy of Dermatology Annual Meeting in San Diego.</li><li>Patients who achieved PASI 90 (90% improvement in psoriasis symptoms) at week 28 maintained their responses through week 72 with continuous treatment.</li><li>The majority of patients who withdrew from treatment at week 28 regained a PASI 90 response within six months of retreatment with TREMFYA.</li><li>Guselkumab is a human monoclonal antibody that binds to&nbsp;<a href=\"https://en.wikipedia.org/wiki/Interleukin_23\" target=\"_blank\">interleukin 23</a>&nbsp;(IL-23), a pro-inflammatory cytokine. It was approved in the U.S. in July 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3278575-fda-oks-j-and-js-guselkumab-plaque-psoriasis\" target=\"_blank\">FDA OKs J&amp;J's guselkumab for plaque psoriasis</a> (July 13, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331938\" data-linked=\"Johnson &amp; Johnson&#39;s Tremfya shows sustained treatment effect in late-stage psoriasis study\" data-tweet=\"$JNJ - Johnson &amp; Johnson&#39;s Tremfya shows sustained treatment effect in late-stage psoriasis study https://seekingalpha.com/news/3331938-johnson-johnsons-tremfya-shows-sustained-treatment-effect-in-late-stage-psoriasis-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3331938-johnson-johnsons-tremfya-shows-sustained-treatment-effect-in-late-stage-psoriasis-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331921\" data-ts=\"1518792207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331921-calampplus-2_4-first-analysts-boosts-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp +2.4% as First Analysts boosts to Overweight</a></h4><ul>   <li>CalAmp (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a>) is <font color='green'>up 2.4%</font> in early going after an upgrade to Overweight from Equal Weight at First Analysis.</li>    <li>The firm raised its price target to $29 from $25, implying 19% upside from yesterday.</li>    <li>Shares are <font color='green'>up 17.3%</font> in the young year to date, and <font color='green'>up 63.6%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331921\" data-linked=\"CalAmp +2.4% as First Analysts boosts to Overweight\" data-tweet=\"$CAMP - CalAmp +2.4% as First Analysts boosts to Overweight https://seekingalpha.com/news/3331921-calampplus-2_4-first-analysts-boosts-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3331921-calampplus-2_4-first-analysts-boosts-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331918\" data-ts=\"1518791777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOGM\" target=\"_blank\">LOGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331918-needham-raises-logmein-target-on-top-line-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham raises LogMeIn target on top-line potential</a></h4><ul><li>        Needham raises its LogMeIn (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a>) price target by $10 to $140, a nearly 5% upside on yesterday&rsquo;s close.</li><li>               Firm cites top-line reset from Analyst Day that sets a beatable base level for the year.&nbsp;</li><li>               Needham also likes the pending Jive acquisition to give a solid footprint in a growth market that could add 1% to 2% to the long-term top line.&nbsp;</li><li>               Source: Briefing.com.&nbsp;&nbsp;</li><li>               LogMeIn shares are&nbsp;<font color='red'>down 4.3%</font>&nbsp;still moving on yesterday&rsquo;s aftermarket news.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331755-google-buying-iot-platform-xively-logmein-50m\" target=\"_blank\">Google buying IoT platform Xively from LogMeIn for $50M</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331918\" data-linked=\"Needham raises LogMeIn target on top-line potential\" data-tweet=\"$LOGM - Needham raises LogMeIn target on top-line potential https://seekingalpha.com/news/3331918-needham-raises-logmein-target-on-top-line-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3331918-needham-raises-logmein-target-on-top-line-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331908\" data-ts=\"1518791051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWL\" target=\"_blank\">NWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331908-newell-brands-beat-estimates-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newell Brands beat estimates in Q4</a></h4><ul><li>Newell Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a>)&nbsp;reports core sales declined 1.9% in <a href=\"https://seekingalpha.com/pr/17077052-newell-brands-announces-fourth-quarter-full-year-2017-results\" target=\"_blank\">Q4</a>.</li><li>Segment net sales: Live: $1.72B (+2.7%, Core sales: -1.8%); Learn: $551M (-8.9%,&nbsp;Core sales: -9.7%); Work: $705M (-3%,&nbsp;Core sales: -1.2%);&nbsp;Play:&nbsp;$563M (+6.6%,&nbsp;Core sales: +5.4%); Other:&nbsp;$198M (-66.7%,&nbsp;Core sales: -0.8%).</li><li>North America net sales dropped 8.7% to $2.85B</li><li>Normalized gross margin squeezed 420 bps to 33%.</li><li>Normalized operating margin rate fell 290 bps to 13.4%.</li><li><b>FY2018 Guidance</b>: Net sales: $14.4B to $14.8B; Core sales: +2.5% to +4%; Normalized EPS: $2.65 to $2.85; Share count: ~489M; Tax rate: 20% to 21%; Operating cash flow: $1.15B to $1.45B.</li><li>NWL&nbsp;<font color='red'>-1.99%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331908\" data-linked=\"Newell Brands beat estimates in Q4\" data-tweet=\"$NWL - Newell Brands beat estimates in Q4 https://seekingalpha.com/news/3331908-newell-brands-beat-estimates-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3331908-newell-brands-beat-estimates-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331902\" data-ts=\"1518790566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331902-premarket-losers-of-9-05-2-16-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (2/16/2018)</a></h4><ul>     <li>APRI&nbsp;<font color='red'>-70%</font>&nbsp;after FDA <a href=\"https://seekingalpha.com/news/3331825-fda-rejects-apricus-bios-ed-cream-vitaros\" target=\"_blank\">rejects</a> ED cream Vitaros.</li><li><a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='red'>-39%</font>.</li><li><a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>&nbsp;<font color='red'>-25%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331885-moleculin-prices-stock-offering-2_10\" target=\"_blank\">pricing</a> stock offering at $2.10.</li><li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-18%</font>.</li><li><a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a>&nbsp;<font color='red'>-18%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3331848-pacira-14-percent-premarket-negative-split-ad-com-vote-exparel\" target=\"_blank\">negative</a> split Ad Com vote on Exparel.</li><li><a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331624-arista-beats-0_30-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>&nbsp;<font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331731-ion-geophysical-launch-public-offering\" target=\"_blank\">announcing</a> proposed public offering of common stock and warrants.</li><li><a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a>&nbsp;<font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331660-impinj-misses-0_09-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/CGNX' title='Cognex Corporation'>CGNX</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331636-cognex-eps-line-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/DM' title='Dominion Midstream Partners LP'>DM</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331616-energous-beats-0_08-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331628-shake-shack-beats-0_04-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3331902\" data-linked=\"Premarket Losers as of 9:05 am (2/16/2018)\" data-tweet=\"$SEEL $SEEL $NNDM - Premarket Losers as of 9:05 am (2/16/2018) https://seekingalpha.com/news/3331902-premarket-losers-of-9-05-2-16-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331902-premarket-losers-of-9-05-2-16-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331901\" data-ts=\"1518790557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCR\" target=\"_blank\">SNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331901-premarket-gainers-of-9-05-02-16-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (02/16/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color='green'>+28%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17076843-synchronoss-announces-closing-convertible-preferred-stock-investment\" target=\"_blank\">closing</a> of convertible preferred stock investment.</li><li><a href='https://seekingalpha.com/symbol/MULE' title='MuleSoft'>MULE</a> <font color='green'>+10%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3331677-mulesoft-eps-line-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='green'>+8%</font>&nbsp;on positive analyst <a href=\"https://seekingalpha.com/news/3331834-premarket-analyst-action-healthcare\" target=\"_blank\">action</a>.</li><li><a href='https://seekingalpha.com/symbol/AUO' title='AU Optronics Corp.'>AUO</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>&nbsp;<font color='green'>+6%</font>&nbsp;as <a href=\"https://seekingalpha.com/news/3331772-intense-flu-season-continue\" target=\"_blank\">intense flu</a> season to continue.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331901\" data-linked=\"Premarket Gainers as of 9:05 am (02/16/2018)\" data-tweet=\"$SNCR $SNCR $MULE - Premarket Gainers as of 9:05 am (02/16/2018) https://seekingalpha.com/news/3331901-premarket-gainers-of-9-05-02-16-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331901-premarket-gainers-of-9-05-02-16-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331892\" data-ts=\"1518789450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXR\" target=\"_blank\">CTXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331892-citius-pharma-commences-late-stage-study-of-mino-lok-in-catheter-related-bloodstream\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citius Pharma commences late-stage study of Mino-Lok in catheter-related bloodstream infections</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17075759-citius-announces-enrollment-first-patient-mino-lok-phase-3-trial\" target=\"_blank\">Enrollment is underway</a> in a 700-subject Phase 3 clinical trial evaluating Citius Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/CTXR' title='Citius Pharmaceuticals Inc.'>CTXR</a>) Mino-Lok in patients with catheter-related bacteremias (bloodstream infections).</li><li>The primary endpoint is the proportion of patients who have Overall Success at test-of-cure at week 8.</li><li><a href=\"https://www.citiuspharma.com/minolok/\" target=\"_blank\">Mino-Lok</a> is an antibiotic lock solution designed to salvage central venous catheters (CVCs). It contains a proprietary combination of minocycline, disodium EDTA and ethyl alcohol.</li><li>CVC-related infections are difficult to treat and present serious complications to patients.</li><li>Shares are down&nbsp;<font color='red'>25%</font>&nbsp;premarket but only on 300 shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331892\" data-linked=\"Citius Pharma commences late-stage study of Mino-Lok in catheter-related bloodstream infections\" data-tweet=\"$CTXR - Citius Pharma commences late-stage study of Mino-Lok in catheter-related bloodstream infections https://seekingalpha.com/news/3331892-citius-pharma-commences-late-stage-study-of-mino-lok-in-catheter-related-bloodstream?source=tweet\" data-url=\"https://seekingalpha.com/news/3331892-citius-pharma-commences-late-stage-study-of-mino-lok-in-catheter-related-bloodstream\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331885\" data-ts=\"1518788531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331885-moleculin-prices-stock-offering-2_10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin prices stock offering at $2.10</a></h4><ul><li>Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) prices its <a href=\"https://seekingalpha.com/pr/17077163-moleculin-announces-pricing-9-million-registered-direct-offering\" target=\"_blank\">direct offering</a> of 4.29M shares of common stock at $2.10 per share. Each share sold will have an accompanying five-year warrant to purchase 1/2 of a share of common at $2.80. Closing date is February 21.</li><li>Yesterday's close was $2.80. Shares are down&nbsp;<font color='red'>4%</font>&nbsp;premarket on modestly higher volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331885\" data-linked=\"Moleculin prices stock offering at $2.10\" data-tweet=\"$MBRX - Moleculin prices stock offering at $2.10 https://seekingalpha.com/news/3331885-moleculin-prices-stock-offering-2_10?source=tweet\" data-url=\"https://seekingalpha.com/news/3331885-moleculin-prices-stock-offering-2_10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331883\" data-ts=\"1518788101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXL\" target=\"_blank\">AXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331883-american-axle-manufacturing-sets-2018-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Axle &amp; Manufacturing sets 2018 targets</a></h4><ul> <li>American Axle &amp; Manufacturing (NYSE:<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a>) says it's targeting sales of about $7B in 2018.</li> <li>The projection is based on the anticipated launch schedule of programs in the company's new and incremental business backlog and assumes a SAAR tally of 16.8M to 17.0M vehicles in the U.S. this year.</li> <li>American Axle also targets an adjusted EBITDA margin rate of 17.5% to 18.0% of sales for 2018 and adjusted free cash flow of 5% of sales.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331858-american-axle-and-manufacturing-beats-0_13-beats-revenue\" target=\"_blank\">American Axle &amp; Manufacturing beats by $0.13, beats on revenue</a> (Feb. 16)</li>  <li>AXL <font color='green'>+5.83%</font> premarket to $16.70.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331883\" data-linked=\"American Axle &amp; Manufacturing sets 2018 targets\" data-tweet=\"$AXL - American Axle &amp; Manufacturing sets 2018 targets https://seekingalpha.com/news/3331883-american-axle-manufacturing-sets-2018-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3331883-american-axle-manufacturing-sets-2018-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331871\" data-ts=\"1518787608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYES\" target=\"_blank\">EYES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331871-second-sight-enters-singapore-first-implant-of-argus-ii-retinal-prosthesis-system\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Second Sight enters Singapore with first implant of Argus II retinal prosthesis system</a></h4><ul> <li>Second Sight Medical Products (NASDAQ:<a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products'>EYES</a>) <a href=\"https://seekingalpha.com/pr/17077129-second-sight-announces-market-entry-singapore-first-implant-argus-ii-retinal-prosthesis\" target=\"_blank\">announces</a> market entry into       Singapore, with the first patient implanted with the Company&rsquo;s <a href=\"http://www.secondsight.com/g-the-argus-ii-prosthesis-system-pf-en.html\" target=\"_blank\">Argus&nbsp;II Retinal Prosthesis System</a>. The implantation was       facilitated by Mandarin Opto-Medic Co Pte.</li>          <li>The implantation was performed at the Singapore National Eye Center on January 18 in a 62-year-old male patient with retinal       degeneration.</li>               <li>Shares are up&nbsp;<font color='green'>12%</font>&nbsp;premarket on light volume.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3331871\" data-linked=\"Second Sight enters Singapore with first implant of Argus II retinal prosthesis system\" data-tweet=\"$EYES - Second Sight enters Singapore with first implant of Argus II retinal prosthesis system https://seekingalpha.com/news/3331871-second-sight-enters-singapore-first-implant-of-argus-ii-retinal-prosthesis-system?source=tweet\" data-url=\"https://seekingalpha.com/news/3331871-second-sight-enters-singapore-first-implant-of-argus-ii-retinal-prosthesis-system\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331872\" data-ts=\"1518787591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331872-qualcomm-still-doesnt-like-broadcoms-offer-open-to-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm still doesn&#39;t like Broadcom&#39;s offer, open to more talks</a></h4><ul><li>        Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <a href=\"https://seekingalpha.com/pr/17077158-qualcomm-provides-update-meeting-broadcom\" target=\"_blank\">releases</a> a letter the company sent to Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) following Wednesday&rsquo;s meeting.</li><li>               Qualcomm&rsquo;s board says that Broadcom&rsquo;s &ldquo;best and final&rdquo; offer of $82 per share &ldquo;materially undervalues Qualcomm and has an unacceptably high level of risk, and therefore is not in the best interests of&nbsp; Qualcomm stockholders.&rdquo;&nbsp;</li><li>               But the board found the meeting constructive since Broadcom seemed willing to agree to antitrust-related divestitures beyond what was included in the public merger agreement.&nbsp;</li><li>               And yet: Broadcom resisted agreeing to other regulatory commitments that could be required by the FTC, European Commission, and MOFCOM, to name a few. The company wouldn&rsquo;t outline its intentions for Qualcomm&rsquo;s licensing business, which could cause antitrust concerns, and insists on controlling all licensing business decisions between signing and closing.&nbsp;</li><li>               Qualcomm says it remains &ldquo;open to further discussions&rdquo; for a better offer.&nbsp;</li><li>               Qualcomm shares are&nbsp;<font color='green'>up 0.7%</font>.&nbsp;</li><li>Broadcom shares are&nbsp;<font color='green'>up 0.5%</font>.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331276-qualcomm-broadcom-discuss-potential-deal\" target=\"_blank\">Qualcomm, Broadcom discuss potential deal</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331872\" data-linked=\"Qualcomm still doesn&#39;t like Broadcom&#39;s offer, open to more talks\" data-tweet=\"$QCOM $QCOM $AVGO - Qualcomm still doesn&#39;t like Broadcom&#39;s offer, open to more talks https://seekingalpha.com/news/3331872-qualcomm-still-doesnt-like-broadcoms-offer-open-to-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3331872-qualcomm-still-doesnt-like-broadcoms-offer-open-to-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331858\" data-ts=\"1518786107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXL\" target=\"_blank\">AXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331858-american-axle-and-amp-manufacturing-beats-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Axle &amp;amp; Manufacturing beats by $0.13, beats on revenue</a></h4><ul><li>American Axle &amp; Manufacturing (NYSE:<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a>): Q4 EPS of $0.89 <font color='green'>beats by $0.13</font>.</li><li>Revenue of $1.73B (+82.8% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+6.46%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17077144-aam-reports-fourth-quarter-full-year-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331858\" data-linked=\"American Axle &amp;amp; Manufacturing beats by $0.13, beats on revenue\" data-tweet=\"$AXL - American Axle &amp; Manufacturing beats by $0.13, beats on revenue https://seekingalpha.com/news/3331858-american-axle-and-amp-manufacturing-beats-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331858-american-axle-and-amp-manufacturing-beats-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331849\" data-ts=\"1518785261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPB\" target=\"_blank\">CPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331849-on-campbell-soups-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Campbell Soup&#39;s Q2</a></h4><ul><li>Campbell Soup (NYSE:<a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a>)&nbsp;reports organic net sales declined 2% in <a href=\"https://seekingalpha.com/pr/17077092-campbell-reports-second-quarter-results\" target=\"_blank\">Q2</a>, driven primarily by lower volumes.</li><li>Total volume and mix slipped 2% for the period.</li><li>Revenue by segments:&nbsp;Americas simple meals and beverages: $1.2B (-2%);&nbsp;Global biscuits and snacks: $726M&nbsp;(+4%);&nbsp;Campbell fresh: $257M&nbsp;(-1%).</li><li>Adjusted gross margin rate down 220 bps to 35.2%, driven primarily by cost inflation and higher supply chain costs, as well as unfavorable mix.</li><li>Adjusted EBIT declined 80 bps to 18.4%.</li><li><b>FY2018 Guidance</b>: Net sales: -1% to +1%; Adjusted EBIT: -7% to -5%; Adjusted EPS: $3.10 to $3.17 (+2% to +4%).</li><li>Denise Morrison, Campbell&rsquo;s President and Chief Executive Officer, said, &ldquo;This was a disappointing quarter, driven by continued challenges in&nbsp;U.S.&nbsp;soup and&nbsp;Campbell Fresh. The decline in organic sales was largely due to the performance of Americas Simple Meals and Beverages, where&nbsp;U.S.&nbsp;soup sales decreased by 7 percent based on the key customer issue we discussed last quarter. We are making progress with this customer and expect sales declines in soup to moderate in the second half.\"</li><li>CPB&nbsp;<font color='red'>-2.73%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331849\" data-linked=\"More on Campbell Soup&#39;s Q2\" data-tweet=\"$CPB - More on Campbell Soup&#39;s Q2 https://seekingalpha.com/news/3331849-on-campbell-soups-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3331849-on-campbell-soups-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331848\" data-ts=\"1518785098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCRX\" target=\"_blank\">PCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331848-pacira-down-14-premarket-after-negative-split-ad-com-vote-on-exparel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacira down 14% premarket after negative split Ad Com vote on Exparel</a></h4><ul><li>Pacira Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a>) is off&nbsp;<font color='red'>14%</font>&nbsp;premarket on light volume after yesterday's 4 - 6 negative vote from an FDA advisory committee on anesthetic drug EXPAREL (bupivacaine liposomal injectable solution).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331606-fda-ad-com-renders-split-vote-paciras-anesnthesia-med-exparel\" target=\"_blank\">FDA Ad Com renders split vote against Pacira's anesnthesia med Exparel</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331848\" data-linked=\"Pacira down 14% premarket after negative split Ad Com vote on Exparel\" data-tweet=\"$PCRX - Pacira down 14% premarket after negative split Ad Com vote on Exparel https://seekingalpha.com/news/3331848-pacira-down-14-premarket-after-negative-split-ad-com-vote-on-exparel?source=tweet\" data-url=\"https://seekingalpha.com/news/3331848-pacira-down-14-premarket-after-negative-split-ad-com-vote-on-exparel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331833\" data-ts=\"1518783444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPB\" target=\"_blank\">CPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331833-campbell-soup-beats-0_19-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Campbell Soup beats by $0.19, beats on revenue</a></h4><ul><li>Campbell Soup (NYSE:<a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a>): Q2 EPS of $1.00 <font color='green'>beats by $0.19</font>.</li><li>Revenue of $2.18B (+0.5% Y/Y) <font color='green'>beats by $20M</font>.</li><li>Shares <font color='green'>+3.04%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17077092-campbell-reports-second-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331833\" data-linked=\"Campbell Soup beats by $0.19, beats on revenue\" data-tweet=\"$CPB - Campbell Soup beats by $0.19, beats on revenue https://seekingalpha.com/news/3331833-campbell-soup-beats-0_19-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331833-campbell-soup-beats-0_19-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331831\" data-ts=\"1518783401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331831-coca-cola-rallies-after-strong-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coca-Cola rallies after strong full-year guidance</a></h4><ul> <li>Coca-Cola (NYSE:<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a>) expects ~4% organic growth in 2018 on a non-GAAP basis.</li> <li>The company expects a 1% tailwind for sales from F/X swings.</li> <li>Full-year profit guidance is set by the company at roughly $2.06 to $2.10 EPS&nbsp;vs. $1.99 consensus.</li> <li>Shares of Coca-Cola are <font color='green'>up 2.50%</font> in premarket trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331827-organic-revenue-6-percent-coca-cola\" target=\"_blank\">Organic revenue up 6% at Coca-Cola</a> (Feb. 16)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331831\" data-linked=\"Coca-Cola rallies after strong full-year guidance\" data-tweet=\"$KO - Coca-Cola rallies after strong full-year guidance https://seekingalpha.com/news/3331831-coca-cola-rallies-after-strong-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3331831-coca-cola-rallies-after-strong-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331827\" data-ts=\"1518782981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331827-organic-revenue-up-6-coca-cola\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Organic revenue up 6% at Coca-Cola</a></h4><ul> <li>Coca-Cola (NYSE:<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a>) reports unit case volume was flat in <a href=\"https://seekingalpha.com/pr/17077058-coca-cola-company-reports-strong-operating-results-fourth-quarter-full-year-2017-achieves\" target=\"_blank\">Q4</a>.</li> <li>Organic revenue was up 6% during the quarter.</li> <li>Organic revenue growth by region: Europe/Middle East/Africa +8%, Latin AMerica +13%, North America +3%, Asia Pacific +1%.</li> <li>Price/mix added four percentage points of organic growth for Coca-Cola, while concentrate sales added a percentage point.</li> <li>Comparable operating margin expanded more than 530 basis points as the divestiture of the lower-margin bottling businesses factored in.</li> <li>Coca-Cola says it added more \"value share\" in the total nonalcoholic ready-to-drink beverage category.</li> <li>CEO update: \"We achieved or exceeded our full year guidance while driving significant change as we continued to transform into a total beverage company. While there is still much work to do, I am encouraged by our momentum as we head into 2018.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331815-coca-cola-eps-line-beats-revenue\" target=\"_blank\">Coca-Cola EPS in-line, beats on revenue</a> (Feb. 16)</li> <li>KO <font color='green'>+1.36%</font> premarket to $45.39.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331827\" data-linked=\"Organic revenue up 6% at Coca-Cola\" data-tweet=\"$KO - Organic revenue up 6% at Coca-Cola https://seekingalpha.com/news/3331827-organic-revenue-up-6-coca-cola?source=tweet\" data-url=\"https://seekingalpha.com/news/3331827-organic-revenue-up-6-coca-cola\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331825\" data-ts=\"1518782973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331825-fda-rejects-apricus-bios-ed-cream-vitaros\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects Apricus Bio&#39;s ED cream Vitaros</a></h4><ul><li>Apricus Biosciences (APRI) is set for an ugly day after <a href=\"https://seekingalpha.com/pr/17077079-apricus-biosciences-receives-complete-response-letter-fda-vitaros\" target=\"_blank\">receiving </a>a Complete Response Letter &#40;CRL&#41; from the FDA regarding its marketing application for topical erectile dysfunction &#40;ED&#41; cream Vitaros (alprostadil, DDAIP.HCl).</li><li>The CRL cited deficiencies in Chemistry, Manufacturing and Control and safety concerns specific to the 2.5% concentration of DDAIP.HCl in the current formulation.</li><li>CEO Richard Pascoe says, &ldquo;We are disappointed with the outcome of the review given the substantial amount of CMC, clinical and non-clinical data and analysis provided to the FDA in the Vitaros resubmission. We are assessing the content of the complete response letter with our regulatory experts, including the information that may be needed to resolve the deficiencies and the time it would take to obtain such information with the goal of providing the market an update on our assessment in early March of this year.\"</li><li><strong>Update</strong>: Trading will resume at 7:30 am ET.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>44%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331825\" data-linked=\"FDA rejects Apricus Bio&#39;s ED cream Vitaros\" data-tweet=\"$SEEL - FDA rejects Apricus Bio&#39;s ED cream Vitaros https://seekingalpha.com/news/3331825-fda-rejects-apricus-bios-ed-cream-vitaros?source=tweet\" data-url=\"https://seekingalpha.com/news/3331825-fda-rejects-apricus-bios-ed-cream-vitaros\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331822\" data-ts=\"1518782770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBC\" target=\"_blank\">WBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331822-on-wabco-holdings-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on WABCO Holdings&#39; Q4</a></h4><ul>     <li>WABCO Holdings (NYSE:<a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a>)&nbsp;reports sales rose 24.3% in local currencies in <a href=\"https://seekingalpha.com/pr/17077051-wabco-s-outstanding-growth-2017-powers-record-sales-solidly-outperforms-global-commercial\" target=\"_blank\">Q4</a>.</li>     <li>Adjusted gross margin rate fell 110 bps to 30.6%.</li>     <li>SG&amp;A expense rate improved 30 bps to 12%.</li>     <li>Adjusted operating margin rate up 60 bps to 15.4%.</li>     <li><b>FY2018 Guidance</b>: Sales: $3.82B to $3.98B (+10% to +15% in local currencies); Adjusted operating margin rate: 14.5% to 14.9%; GAAP operating margin rate: 13.8% to 14.2%; Adjusted net income: $384.5M to $411.2M; GAAP net income: $361.2M to $387.9M; Adjusted EPS: $7.20 to $7.70; Diluted EPS: $6.76 to $7.26; Diluted shares&nbsp;outstanding: ~53M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331822\" data-linked=\"More on WABCO Holdings&#39; Q4\" data-tweet=\"$WBC - More on WABCO Holdings&#39; Q4 https://seekingalpha.com/news/3331822-on-wabco-holdings-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3331822-on-wabco-holdings-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331817\" data-ts=\"1518782333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331817-apricus-biosciences-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus Biosciences shares halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading</a> in Apricus Biosciences (APRI) pending the release of news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331817\" data-linked=\"Apricus Biosciences shares halted pending news\" data-tweet=\"$SEEL - Apricus Biosciences shares halted pending news https://seekingalpha.com/news/3331817-apricus-biosciences-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3331817-apricus-biosciences-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331815\" data-ts=\"1518782290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331815-coca-cola-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coca-Cola EPS in-line, beats on revenue</a></h4><ul><li>Coca-Cola (NYSE:<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a>): Q4 EPS of $0.39 in-line.</li><li>Revenue of $7.5B (-20.0% Y/Y) <font color='green'>beats by $140M</font>.</li><li>Shares <font color='green'>+1.5%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17077058-coca-cola-company-reports-strong-operating-results-fourth-quarter-full-year-2017-achieves\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331815\" data-linked=\"Coca-Cola EPS in-line, beats on revenue\" data-tweet=\"$KO - Coca-Cola EPS in-line, beats on revenue https://seekingalpha.com/news/3331815-coca-cola-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331815-coca-cola-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331807\" data-ts=\"1518781519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJM\" target=\"_blank\">SJM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331807-on-j-m-smuckers-q3-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on J.M. Smucker&#39;s Q3 earnings beat</a></h4><ul><li>J.M. Smucker (NYSE:<a href='https://seekingalpha.com/symbol/SJM' title='J. M. Smucker Company'>SJM</a>)&nbsp;reports net sales rose 1% in <a href=\"https://seekingalpha.com/pr/17077036-j-m-smucker-company-announces-fiscal-2018-third-quarter-results\" target=\"_blank\">Q3</a>,&nbsp;reflecting growth across most of the Company's key brands and categories..</li><li>Revenue by segment:&nbsp;U.S. Retail Coffee: $550.5M (+2%);&nbsp;U.S. Retail Consumer Foods: $511.6M (-1%);&nbsp;U.S. Retail Pet Foods: $561.9M (+2%);&nbsp;International and Away from Home: $279.3M (+2%).</li><li>Adjusted gross margin rate down 10 bps to 38.4%.</li><li>Adjusted operating margin rate improved 60 bps to 21%.</li><li>EBITDA margin advanced 90 bps to 23.1%.</li><li><b>FY2018 Guidance</b>: Net sales:&nbsp;flat to down slightly; Adjusted non-GAAP EPS: $8.20 - $8.30; Tax rate: 28%; Shares outstanding: 113.6M; Free cash flow: $825M; Capex: $310M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331807\" data-linked=\"More on J.M. Smucker&#39;s Q3 earnings beat\" data-tweet=\"$SJM - More on J.M. Smucker&#39;s Q3 earnings beat https://seekingalpha.com/news/3331807-on-j-m-smuckers-q3-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3331807-on-j-m-smuckers-q3-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":56,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}